FDA Inspection
Arzol Chemical CompanyArzol Chemical Company – FDA Inspection, Jun 14, 2024
Record Details
This FDA Inspection record concerns Arzol Chemical Company, with an inspection on June 14, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · db5b24f2-17e3-4e67-bfb9-d5069f99d3aa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1241346
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs
- 21 CFR 211.84(d)(3)Establish reliability of supplier"s C of A
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.84(d)(3)Establish reliability of supplier's C of A
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Arzol Chemical Company
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 25, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 23, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 19, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 14, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Arzol Chemical Company
- FDA Inspection 958730 - 2016-01-25
- FDA Inspection 869538 - 2014-01-23
- FDA Inspection 759807 - 2011-12-19
- FDA Inspection 599328 - 2009-07-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.